Mandl Erik W, van der Veen Simone W, Verhaar Jan A N, van Osch Gerjo J V M
Department of Orthopaedics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Tissue Eng. 2002 Aug;8(4):573-80. doi: 10.1089/107632702760240490.
For tissue engineering of autologous cartilage, cell expansion is needed to obtain the cell numbers required. Standard expansion media contain bovine serum. This has several disadvantages, that is, the risk of transmitting diseases and serum-batch variations. The aim of this study was to find a serum-free medium with at least the same potential to expand cell numbers as serum-containing media. Ear chondrocytes of three young children were expanded in either serum-containing medium (SCM; DMEM with 10% fetal calf serum) or serum-free medium (SFM; DMEM with ITS+) supplemented with 5 or 100 ng/mL fibroblast growth factor-2 (FGF2). To promote cell adherence onto the culture flask, the serum-free conditions were cultured with 10% serum for 1 day after each trypsinization. After the fourth passage, the chondrocytes were encapsuled in alginate beads and redifferentiated in a SFM (DMEM with ITS+, hydrocortisone, and L-ascorbic acid) supplemented with 10 ng/mL IGF-I and 10 ng/mL TGFbeta-2. Results showed that expansion in SFM with 100 ng/mL FGF2 was comparable to expansion in SCM. Redifferentiation with SFM with IGF-I and TGFbeta-2 showed high collagen type II expression and high GAG/DNA production regardless of which expansion medium had been used. However, chondrocytes expanded in SFM with 100 ng/mL FGF2 resulted in less positive cells for collagen type I and 11-fibrau (a fibroblast membrane marker). The present study shows that it is possible to use serum-free medium for tissue engineering of cartilage. Expansion of immature ear chondrocytes in SFM supplemented with high-concentration FGF2 resulted in high cell numbers, which in addition had better redifferentiation capacity than cells expanded in medium with 10% serum.
对于自体软骨组织工程而言,需要进行细胞扩增以获得所需的细胞数量。标准的扩增培养基含有牛血清。这存在几个缺点,即有传播疾病的风险以及血清批次差异。本研究的目的是找到一种无血清培养基,其扩增细胞数量的潜力至少与含血清培养基相同。三名幼儿的耳软骨细胞在含血清培养基(SCM;含10%胎牛血清的DMEM)或无血清培养基(SFM;含ITS+的DMEM)中进行扩增,后者添加了5或100 ng/mL的成纤维细胞生长因子-2(FGF2)。为促进细胞黏附到培养瓶上,每次胰蛋白酶消化后,无血清条件下用10%血清培养1天。在第4代后,将软骨细胞包封在藻酸盐珠中,并在添加了10 ng/mL胰岛素样生长因子-I(IGF-I)和10 ng/mL转化生长因子-β2(TGFβ-2)的SFM(含ITS+、氢化可的松和L-抗坏血酸的DMEM)中进行再分化。结果表明,添加100 ng/mL FGF2的SFM中的扩增效果与SCM中的相当。无论使用哪种扩增培养基,用添加IGF-I和TGFβ-2的SFM进行再分化均显示出高II型胶原蛋白表达和高糖胺聚糖/DNA产量。然而,在添加100 ng/mL FGF-2的SFM中扩增的软骨细胞导致I型胶原蛋白和11-纤维连接蛋白(一种成纤维细胞膜标志物)的阳性细胞较少。本研究表明,无血清培养基可用于软骨组织工程。在添加高浓度FGF2的SFM中扩增未成熟耳软骨细胞可获得高细胞数量,此外,其再分化能力比在含10%血清的培养基中扩增的细胞更好。